4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-26-277529
Director sold 84,355 shares at an average $20.10 ($1,695,689)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kersten Dirk Director | 2026-06-17 | Sale 10b5-1 | −37,454 | $20.14 | $754,316 | 4,159,119 | I: show line 1 in the form |
| Kersten Dirk Director | 2026-06-18 | Sale 10b5-1 | −46,901 | $20.07 | $941,373 | 4,112,218 | I: show line 2 in the form |
| Open-market sales · 84,355 sh · avg $20.10 · $1,695,689 | |||||||
Loading xslF345X06/ownership.xml…